NEW YORK, June 26 - Eli Lilly will establish a new research facility in Singapore to study systems biology, the company said Tuesday. 

The R&D facility, which will employ up to 50 scientists when it opens by 2002, is the first biomedical research center to receive support from Singapore's $600 million R&D fund designed to bring private investment in biomedicine and biotechnology to Singapore.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.